Share This

Related Topics News - Drugs

     
 < Previous page   Title only   |   Print    Next page > 
     
康哲藥業獲1類新藥ABP-671獨家商業化權利

2024-12-02T  
《業績》精優藥業中期純利1.01億元 虧轉盈

2024-12-01T  
白雲山附屬以逾5.2億人民幣向興證資管應收賬款

2024-11-28T  
國家醫保局:協議期內談判藥品累計為患者減負逾8,800億人幣

2024-11-28T  
新版國家醫保藥品目錄新增91種藥品 預計明年為患者減負逾500億人幣

2024-11-28T  
康哲藥業創新藥CMS-D005獲准開展臨床試驗

2024-11-28T  
《盈喜》精優藥業料中期虧轉盈 賺最多1.05億元

2024-11-19T  
盧寵茂:「1+」機制累計批出5款新藥申請 其中2款藥物成本下降近30%

2024-11-08T  
康哲藥業磷酸蘆可替尼乳膏香港新藥上市申請獲批

2024-11-06T  
衛生署:「1+」審批機制11月起擴展至所有新藥 體現「好藥港用」

2024-10-25T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.